Showing 81 - 100 results of 393 for search '"Multiple sclerosis"', query time: 0.10s Refine Results
  1. 81
  2. 82

    A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis by Ramy Mando, Emile Muallem, Shaiva G. Meka, Ramona Berghea

    Published 2018-01-01
    “…Tumefactive Multiple Sclerosis (TMS) is a rare variant with 1 per 1000 cases of MS and 3 per million cases per year. …”
    Get full text
    Article
  3. 83

    Intensive Farmaco- Surveillance of Interferon Alpha 2b Recombinant in Multiple Sclerosis. by Leslie Pérez Ruiz, Ana María Ramos Cedeño, José Cabrera Gómez, Nancy Echazábal Santana, Hailen Bobillo López

    Published 2007-12-01
    “…This trial was developed in the Clinic of Multiple Sclerosis of the Hospital "Dr. Gustavo Aldereguía Lima" in Cienfuegos. …”
    Get full text
    Article
  4. 84

    Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis by E Gibbons, S Promislow, RA Davies, G Chandy, DJ Stewart, V Contreras-Dominguez, C Pugliese, R Dunne, LM Mielniczuk

    Published 2015-01-01
    “…The authors present a case involving a patient with multiple sclerosis with no known risk factors for PAH, who developed severe PAH after exposure to IFN therapy. …”
    Get full text
    Article
  5. 85

    A Mechanistic, Stochastic Model Helps Understand Multiple Sclerosis Course and Pathogenesis by Isabella Bordi, Renato Umeton, Vito A. G. Ricigliano, Viviana Annibali, Rosella Mechelli, Giovanni Ristori, Francesca Grassi, Marco Salvetti, Alfonso Sutera

    Published 2013-01-01
    “…Heritable and nonheritable factors play a role in multiple sclerosis, but their effect size appears too small, explaining relatively little about disease etiology. …”
    Get full text
    Article
  6. 86
  7. 87
  8. 88

    Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features by Ozgul Ekmekci

    Published 2017-01-01
    “…Multiple sclerosis (MS) is an inflammatory demyelinating and neurodegenerative disease. …”
    Get full text
    Article
  9. 89
  10. 90
  11. 91

    Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis by Leyla Baysal Kıraç, Özgül Ekmekçi, Nur Yüceyar, Ayşe Sağduyu Kocaman

    Published 2014-01-01
    “…The aim of our study was to investigate the frequency and pattern of cognitive impairment in patients with clinically isolated syndromes and definite diagnosis of multiple sclerosis within the last 2 years. Methods. We assessed the cognitive status of 46 patients aged 18–49 years with clinically isolated syndromes or definite diagnosis of multiple sclerosis who have onset of their symptoms within the last 2 years. …”
    Get full text
    Article
  12. 92
  13. 93
  14. 94

    Sexual Satisfaction in Fully Ambulatory People with Multiple Sclerosis: Does Disability Matter? by Pawel Dobrakowski, Agnieszka Machowska-Majchrzak, Beata Labuz-Roszak, Ewa Niewiadomska, Krystyna Pierzchala

    Published 2020-01-01
    “…The subjects completed the Montgomery-Asberg Depression Scale (MADRS), the Coping Inventory for Stressful Situations (CISS), the Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-19), and the Sexual Satisfaction Questionnaire (SSQ). …”
    Get full text
    Article
  15. 95
  16. 96

    The Main Determinants for Suicidal Ideation in a Romanian Cohort of Multiple Sclerosis Patients by Andreea Romaniuc, Rodica Bălaşa, Nicoleta Ştirbu, Smaranda Maier, Sebastian Andone, Zoltan Bajko, Laura Bărcuţean, Septimiu Voidăzan, Anca Moţăţăianu

    Published 2020-01-01
    “…To determine the prevalence of suicidal concerns (SC) in a large multiple sclerosis (MS) patient group and to assess the major determinants that are implicated in their occurrence. …”
    Get full text
    Article
  17. 97
  18. 98

    Neuroendocrine Cell Carcinoma of Unknown Primary Arising in Long Standing History of Multiple Sclerosis by Stergios Boussios, Vasiliki Kostadima, Anna Batistatou, Ioannis Tourkantonis, George Fotopoulos, Maria I. Argyropoulou, Nicholas Pavlidis

    Published 2015-01-01
    “…Multiple sclerosis (MS) is a chronic autoimmune disease that targets myelinated axons in the central nervous system (CNS). …”
    Get full text
    Article
  19. 99
  20. 100

    Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis by Làzaro Aurelio Vàzquez Gòmez, Carlos Hidalgo Mesa, Yunier Broche Pèrez, Yanet Valdés Morales

    Published 2022-10-01
    “…<p><strong>Background:</strong> multiple sclerosis modifying drugs are intended to reduce the frequency of relapses, delay the progression of disability, as well as the appearance of new lesions in the Central Nervous System.…”
    Get full text
    Article